Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome

Inclusion Criteria: * With a Body Mass Index (BMI) more than or equal to 25 kg/m² and less than 40 kg/m², * With a metabolic syndrome characterized by a a waist circumference of more than 94 cm for the males (90 cm for South-Asians, Chinese and Japanese) and more than 80 cm for the females, and at least 2 of the following criteria : * Arterial Blood pressure \> or = 130 mmHg (systolic) and/or more than or equal to 85 mmHg (diastolic) or stabilized with treatment for at least 6 months, * Fasting glycemia \> or = 1 g/L or 5.6 mmol/L or stabilized with treatment for at least 6 months and non-diabetic \< 1.26 g/L, * Triglycerides \> or = 1.5 g/L or 1.71 mmol/L or stabilized with treatment for at least 6 months, * HDL Cholesterol \<0.40 g/L or 1.03 mmol/L (males) and \<0,5 g/l or 1.29 mmol/L (females) or stabilized with treatment for at least 6 months. Exclusion Criteria: * Pregnant (positive pregnancy test at the selection visit or breast-feeding woman, * Woman of childbearing potential without an efficient contraception method, The above information is not intended to contain all considerations relevant to a patient's potential participation in the clinical trial